FOURTH EXTENSION - GRANTED
granted
on 25 Oct 2024
Last Applicant/ Owned by
EPFL INNOVATION PARK, BÂTIMENT E
LAUSANNE
CH
1015
Serial Number
90905974 filed on 27th Aug 2021
Registration Number
N/A
Correspondent Address
Joshua S. Jarvis, Esq.
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
VANDRIA
Research and development of pharmaceuticals in the fields of mitochondrial diseases, disorders, and conditions, cardiovascular diseases, disorders, and conditions, musculoskeletal diseases, disorders, and conditions, muscular diseases, disorders, and conditions, bone diseases, disorders, and conditions, neurological and neurodegenerative diseases, disorders, and conditions, metabolic diseases, dis Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Research and development of pharmaceuticals in the fields of mitochondrial diseases, disorders, and conditions, cardiovascular diseases, disorders, and conditions, musculoskeletal diseases, disorders, and conditions, muscular diseases, disorders, and conditions, bone diseases, disorders, and conditions, neurological and neurodegenerative diseases, disorders, and conditions, metabolic diseases, disorders, and conditions, renal diseases, disorders, and conditions, ophthalmological diseases, disorders, and conditions, oncological diseases, disorders, and conditions, immune system and autoimmune diseases, disorders, and conditions, endocrine system diseases, disorders, and conditions, pulmonary and respiratory diseases, disorders, and conditions, hepatic diseases, disorders, and conditions, gastrointestinal diseases, disorders, and conditions, and diseases, disorders, and conditions related to aging
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceuticals for the treatment of mitochondrial diseases, disorders, and conditions, cardiovascular diseases, disorders, and conditions, musculoskeletal diseases, disorders, and conditions, muscular diseases, disorders, and conditions, bone diseases, disorders, and conditions, neurological and neurodegenerative diseases, disorders, and conditions, metabolic diseases, disorders, and conditions, renal diseases, disorders, and conditions, ophthalmological diseases, disorders, and conditions, oncological diseases, disorders, and conditions, immune system and autoimmune diseases, disorders, and conditions, endocrine system diseases, disorders, and conditions, pulmonary and respiratory diseases, disorders, and conditions, hepatic diseases, disorders, and conditions, gastrointestinal diseases, disorders, and conditions, and diseases, disorders, and conditions related to aging
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 90905974
Mark Type
No Service Mark
Attorney Docket Number
No 29120.00006
44D Filed
Yes
44D Current
No
44E filed
No
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 25th Oct 2024 | SOU EXTENSION 4 FILED |
| 25th Oct 2024 | SOU EXTENSION 4 GRANTED |
| 25th Oct 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 25th Oct 2024 | SOU TEAS EXTENSION RECEIVED |
| 09th Apr 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 08th Apr 2024 | SOU TEAS EXTENSION RECEIVED |
| 08th Apr 2024 | SOU EXTENSION 3 FILED |
| 08th Apr 2024 | SOU EXTENSION 3 GRANTED |
| 20th Sep 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 18th Sep 2023 | SOU EXTENSION 2 GRANTED |